Articles By Anuja Singh
Is AI-Engineered HMBD-002 the Next Big Immunotherapy? Hummingbird Bioscience Signs $290M Global Licensing Deal…
Key Highlights Strategic Global Licensing Deal Hummingbird Bioscience has signed a worldwide licensing agreement with Percheron Therapeutics for…
By
Can ProFound Therapeutics and Novartis’ $750M AI-Driven Cardiovascular Pact Redefine Drug Discovery from the…
Key Highlights AI Meets Proteomics: A New Paradigm in Cardiovascular DiscoveryIn a bold step toward AI-enabled medicine, ProFound…
Is Insilico’s AI-Driven UAE University Alliance the Catalyst for a New Generation of Biotech…
Key Highlights Academic Meets AI Innovation in UAEInsilico Medicine, a leader in generative AI for drug discovery, has…
How Abridge’s $5.3B AI Surge Is Transforming Clinical Documentation and Revenue Cycles in U.S.…
Key Insights: Andreessen Horowitz Leads $300M Bet on Abridge’s Healthcare AI VisionAndreessen Horowitz (A16z) has doubled down on…
Why Sutter Health’s Strategic AI Partnership with Aidoc Could Set the Benchmark for System-Wide…
Key Highlights Strategic Collaboration to Scale Clinical AISutter Health has announced a multi-year strategic partnership with Aidoc, embedding…
Is Sanofi’s $632M AI Bet on Formation Bio the Next Big Immunology Breakthrough?
French pharma giant doubles down on AI-native R&D with gusacitinib licensing deal targeting new inflammatory indication Key Takeaways…
Is AI-Engineered HMBD-002 the Next Big Immunotherapy? Hummingbird Bioscience Signs $290M Global Licensing Deal…
Key Highlights Strategic Global Licensing Deal Hummingbird Bioscience has signed a worldwide licensing agreement with Percheron Therapeutics for…
Can ProFound Therapeutics and Novartis’ $750M AI-Driven Cardiovascular Pact Redefine Drug Discovery from the…
Key Highlights AI Meets Proteomics: A New Paradigm in Cardiovascular DiscoveryIn a bold step toward AI-enabled medicine, ProFound…
Is Insilico’s AI-Driven UAE University Alliance the Catalyst for a New Generation of Biotech…
Key Highlights Academic Meets AI Innovation in UAEInsilico Medicine, a leader in generative AI for drug discovery, has…
How Abridge’s $5.3B AI Surge Is Transforming Clinical Documentation and Revenue Cycles in U.S.…
Key Insights: Andreessen Horowitz Leads $300M Bet on Abridge’s Healthcare AI VisionAndreessen Horowitz (A16z) has doubled down on…
Why Sutter Health’s Strategic AI Partnership with Aidoc Could Set the Benchmark for System-Wide…
Key Highlights Strategic Collaboration to Scale Clinical AISutter Health has announced a multi-year strategic partnership with Aidoc, embedding…
Is Sanofi’s $632M AI Bet on Formation Bio the Next Big Immunology Breakthrough?
French pharma giant doubles down on AI-native R&D with gusacitinib licensing deal targeting new inflammatory indication Key Takeaways…